» Articles » PMID: 7812701

Pulmonary Infections in Lung Cancer Patients at Diagnosis

Overview
Journal Lung Cancer
Specialty Oncology
Date 1994 Sep 1
PMID 7812701
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We carried out a prospective study involving 96 consecutive lung cancer patients at diagnosis, in order to determine through quantitative cultures of the bronchoalveolar lavage (BAL) fluid, the prevalence of pulmonary infections; we also evaluated the relationship between a patient's performance status, immunocompetence, lung cancer stage, histotype and the occurrence of respiratory infections. The patients (81 males, 15 females) had a mean age of 64 +/- 9 years. Of these, 62 were smokers, 30 were ex-smokers and four had never smoked. Sixty-seven patients had a prior history of chronic bronchitis. A total of 42 micro-organisms were cultured from the BAL fluids of 33 patients (34.3%). Fifty percent of these micro-organisms were gram-negative, 33.3% were gram-positive and the remaining 16.7% were other micro-organisms. The bacilli most often isolated were the Haemophilus species, accounting for 38.8% of all gram-negative bacilli. The most frequently isolated gram-positive pathogen was the Staphylococcus aureus. We have not found a significant relationship between the presence of a respiratory infection and the different cell types separately analyzed, nor with SCLC and NSCLC patient groups, nor with the stage of the disease. The performance status, the immunoregulatory ratio and the lymphocyte subsets were not significantly different in patients with or without a pulmonary infection. We think that the identification of a definite etiologic agent is of great importance for a rational anti-microbial treatment of pulmonary infections.

Citing Articles

Characterising the impact of pneumonia on outcome in non-small cell lung cancer: identifying preventative strategies.

Patel A, Nightingale P, Naidu B, Drayson M, Middleton G, Richter A J Thorac Dis. 2020; 12(5):2236-2246.

PMID: 32642129 PMC: 7330320. DOI: 10.21037/jtd.2020.04.49.


Alpha1-antitrypsin protects lung cancer cells from staurosporine-induced apoptosis: the role of bacterial lipopolysaccharide.

Schwarz N, Tumpara S, Wrenger S, Ercetin E, Hamacher J, Welte T Sci Rep. 2020; 10(1):9563.

PMID: 32533048 PMC: 7293251. DOI: 10.1038/s41598-020-66825-w.


Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines.

Gokyildirim M, Grandel U, Hattar K, Dahlem G, Schuetz E, Leinberger F Oncotarget. 2018; 9(48):28976-28988.

PMID: 29989005 PMC: 6034744. DOI: 10.18632/oncotarget.25665.


The role of bacterial culture by bronchoscopy in patients with lung cancer: a prospective study.

Koslow M, Epstein Shochet G, Matveychuk A, Israeli-Shani L, Guber A, Shitrit D J Thorac Dis. 2018; 9(12):5300-5305.

PMID: 29312739 PMC: 5756955. DOI: 10.21037/jtd.2017.10.150.


Retrospective analysis of the microbiological spectrum of pneumonia in Turkish patients with lung cancer.

Avci N, Hartavi M, Kacan T, Bayindir M, Avci M, Ozakin C Contemp Oncol (Pozn). 2016; 20(1):63-6.

PMID: 27095942 PMC: 4829750. DOI: 10.5114/wo.2016.58502.